Back
Entrada Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
TRDA
Entrada Therapeutics, Inc.
Last Price:
$10.96
Seasonality Move:
-39.89%
7 Day Trial
ALL ACCESS PASS
$
7
Entrada Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Entrada Therapeutics, Inc. has on average historically fallen by 7.7% based on the past 4 years of stock performance.
-
Entrada Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Entrada Therapeutics, Inc. Stock Undervalued?The current Entrada Therapeutics, Inc. [TRDA] share price is $10.98. The Score for TRDA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Entrada Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Entrada Therapeutics, Inc. has on average historically fallen by 7.7% based on the past 4 years of stock performance.
Entrada Therapeutics, Inc. Stock Rating
Buy
54
Entrada Therapeutics, Inc. (TRDA)
is a Buy
Is Entrada Therapeutics, Inc. overpriced?
-
Entrada Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Entrada Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com
52-Week Data
52-Week High:
18.76
52-Week Low:
4.93
Prediction Charts
Market Cap:
419.6M
Price in USD:
10.98
Volume:
229.1K
Beta:
-0.12
Technical Analysis
SMA50:
8.48
SMA100:
7.01
SMA200:
7.59
52-Wk Change:
-36.46%
Stock Predictions
-
Is Entrada Therapeutics, Inc. stock public?Yes, Entrada Therapeutics, Inc. is a publicly traded company.
-
What is the Entrada Therapeutics, Inc. stock quote today?The Entrada Therapeutics, Inc. stock price is 10.98 USD today.
-
How to buy Entrada Therapeutics, Inc. stock online?You can buy Entrada Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 9.80 | 9.85 | 9.99 | 9.49 |
| Dec-3 | 9.84 | 10.07 | 10.12 | 9.40 |
| Dec-4 | 9.94 | 10.16 | 10.38 | 9.52 |
| Dec-5 | 10.20 | 10.32 | 10.40 | 10.15 |
| Dec-8 | 10.42 | 11.04 | 11.07 | 10.41 |
| Dec-9 | 11.04 | 10.59 | 11.24 | 10.52 |
| Dec-10 | 10.54 | 10.59 | 10.77 | 10.40 |
| Dec-11 | 10.60 | 10.81 | 11.05 | 10.52 |
| Dec-12 | 10.83 | 11.08 | 11.15 | 10.61 |
| Dec-15 | 11.17 | 11.03 | 11.36 | 10.85 |
| Dec-16 | 11.05 | 11.37 | 11.44 | 10.82 |
| Dec-17 | 11.36 | 11.22 | 11.51 | 11.11 |
| Dec-18 | 11.28 | 10.96 | 11.55 | 10.90 |
| Dec-19 | 10.91 | 10.98 | 11.25 | 10.68 |
Entrada Therapeutics, Inc. Earnings
Entrada Therapeutics, Inc. Earnings Report: Per Share Entrada Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Entrada Therapeutics, Inc. Forecast Revenue Growth
Entrada Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.44 per share, and a decrease next year of $0.64 per share.
* Entrada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.